On or around 11/23/2020 (Date of last review)
Filing Date: January 23, 2020
According to the Complaint, Geron Corporation is a biopharmaceutical company with its headquarters located in Menlo Park, California.
The Complaint alleges that throughout the Class Period, Defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, the Complaint alleges that Defendants: (1) misled investors about the results of a clinical drug study of imetelstat called IMbark; and (2) as a result, Defendants' statements about Geron's business, operations, and prospects were materially false and misleading and lacked a reasonable basis at all relevant times.
On May 14, 2020, the Court issued an Order consolidating cases and appointing Lead Plaintiffs. On July 27, the Court approved Lead Plaintiffs' Selection of Counsel. Lead Plaintiffs filed a consolidated Complaint on August 20. On October 22, Lead Plaintiffs filed an amended consolidated Complaint.
Company & Securities Information
Defendant: Geron Corporation
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: GERN
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Michael Tollen, et al. v. Geron Corporation, et al.
COURT: N.D. California
DOCKET #: 20-CV-00547
JUDGE: Hon. William Alsup
DATE FILED: 01/23/2020
CLASS PERIOD START: 03/19/2018
CLASS PERIOD END: 09/26/2018
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Johnson Fistel, LLP
First Identified Complaint (FIC) Filings:
Class Action Complaint for Violation of the Federal Securities Laws
Related Case Order
Related Case Order
U.S. District Court Civil Docket
Order (1) Consolidating Actions; (2) Appointing Lead Plaintiff; and (3) Inviting Applications for Lead Counsel
Order Approving Lead Plaintiffs' Selection of Counsel